Studies further demonstrate that ipamorelin suppresses myostatin expression, a negative regulator of muscle mass, and inhibits muscle atrophy signaling pathways
GLP-1 receptor agonists slow gastric emptying, which can impair B12 absorption from food
FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation
The results showed that tirzepatide was more effective in reducing body weight than semaglutide at all respective doses, reporting figures of -6.2kg, -8.8g, and -11.0kg and for tirzepatide 5.0mg, 10.0mg, and 15.0mg, respectively, versus -2.7kg, -4.4kg, and -5.2kg for semaglutide 0.5mg, 1.0mg, and 2.0mg, respectively
Vision changes: Diabetic patients may experience worsening diabetic retinopathy during rapid blood sugar improvements